FODMAPs (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols) have gained increasing attention in the scientific community due to their significant role in managing gastrointestinal disorders, particularly irritable bowel syndrome (IBS). These short-chain carbohydrates are poorly absorbed in the small intestine, leading to fermentation by gut bacteria, which can trigger symptoms such as bloating, abdominal pain, and altered bowel habits. Over the last decade, the low-FODMAP diet has been widely adopted as an effective therapeutic approach, offering symptom relief for many patients. However, ongoing research seeks to further elucidate the mechanisms behind FODMAP sensitivity and its long-term impact on gut health and microbiota composition.
The goal of this Research Topic is to consolidate and showcase cutting-edge research on FODMAPs and their impact on gastrointestinal health, from both clinical and basic science perspectives. We aim to explore advances in understanding FODMAP metabolism, dietary management strategies, and their interaction with the gut microbiota. Additionally, we encourage contributions that investigate new therapeutic approaches, potential biomarkers for FODMAP sensitivity, and long-term effects of the low-FODMAP diet on overall health. This issue also welcomes interdisciplinary studies that consider FODMAPs' role in nutrition, psychology, and public health, providing a comprehensive perspective on how these compounds influence diet and digestive well-being.
We invite researchers and clinicians to submit original research articles, reviews, meta-analyses, and clinical case studies related to FODMAPs. Submissions may address topics such as the physiological and molecular mechanisms of FODMAP sensitivity, innovations in dietary management, the role of gut microbiota in FODMAP-related symptoms, and the clinical application of low-FODMAP diets. This Research Topic seeks to advance understanding of the interplay between diet and gut health, and to highlight practical implications for treating gastrointestinal disorders. Authors should adhere to the journal's submission guidelines and ensure that all studies comply with ethical standards for human or animal research. Themes of interest include, but are not limited to:
• FODMAPs: Review, conceptual description, criticism, doubts, debates, and discussions about the low-FODMAP diet.
• Bromatology: Ingredients, lists, diets, and FODMAPs.
• Apps and technology for patient/end-user use.
• FODMAPs and microbiota.
• Use of a low-FODMAP diet in clinical trials for various conditions and pathologies, including IBS, IBD, cancer, constipation, diarrhoea, autism, dementia, fibromyalgia, osteoarthritis, polycystic ovary syndrome, and endometriosis.
• Limitations of use: Considerations for vegans, vegetarians, restrictive diet perspectives, psychology, and eating disorders.
Topic Editor Dr. Ismael San Mauro Martín is co-founder of Research Centres in Nutrition and Health Inc., member of the scientific committee of the DAO Deficiency International Society, and member of the scientific committee of Dr. Schar Institute. Topic Editor Dr. Marta Stelmach-Madras declares no competing interests with regard to the Research Topic subject.
Keywords:
FODMAP, Fructose, Lactose, Oligosaccharides, Disaccharides, Monosaccharides, Polyols, Gastrointestinal Disorders, Irritable Bowel Syndrome, Gut Microbiota, Diet Intervention
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
FODMAPs (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols) have gained increasing attention in the scientific community due to their significant role in managing gastrointestinal disorders, particularly irritable bowel syndrome (IBS). These short-chain carbohydrates are poorly absorbed in the small intestine, leading to fermentation by gut bacteria, which can trigger symptoms such as bloating, abdominal pain, and altered bowel habits. Over the last decade, the low-FODMAP diet has been widely adopted as an effective therapeutic approach, offering symptom relief for many patients. However, ongoing research seeks to further elucidate the mechanisms behind FODMAP sensitivity and its long-term impact on gut health and microbiota composition.
The goal of this Research Topic is to consolidate and showcase cutting-edge research on FODMAPs and their impact on gastrointestinal health, from both clinical and basic science perspectives. We aim to explore advances in understanding FODMAP metabolism, dietary management strategies, and their interaction with the gut microbiota. Additionally, we encourage contributions that investigate new therapeutic approaches, potential biomarkers for FODMAP sensitivity, and long-term effects of the low-FODMAP diet on overall health. This issue also welcomes interdisciplinary studies that consider FODMAPs' role in nutrition, psychology, and public health, providing a comprehensive perspective on how these compounds influence diet and digestive well-being.
We invite researchers and clinicians to submit original research articles, reviews, meta-analyses, and clinical case studies related to FODMAPs. Submissions may address topics such as the physiological and molecular mechanisms of FODMAP sensitivity, innovations in dietary management, the role of gut microbiota in FODMAP-related symptoms, and the clinical application of low-FODMAP diets. This Research Topic seeks to advance understanding of the interplay between diet and gut health, and to highlight practical implications for treating gastrointestinal disorders. Authors should adhere to the journal's submission guidelines and ensure that all studies comply with ethical standards for human or animal research. Themes of interest include, but are not limited to:
• FODMAPs: Review, conceptual description, criticism, doubts, debates, and discussions about the low-FODMAP diet.
• Bromatology: Ingredients, lists, diets, and FODMAPs.
• Apps and technology for patient/end-user use.
• FODMAPs and microbiota.
• Use of a low-FODMAP diet in clinical trials for various conditions and pathologies, including IBS, IBD, cancer, constipation, diarrhoea, autism, dementia, fibromyalgia, osteoarthritis, polycystic ovary syndrome, and endometriosis.
• Limitations of use: Considerations for vegans, vegetarians, restrictive diet perspectives, psychology, and eating disorders.
Topic Editor Dr. Ismael San Mauro Martín is co-founder of Research Centres in Nutrition and Health Inc., member of the scientific committee of the DAO Deficiency International Society, and member of the scientific committee of Dr. Schar Institute. Topic Editor Dr. Marta Stelmach-Madras declares no competing interests with regard to the Research Topic subject.
Keywords:
FODMAP, Fructose, Lactose, Oligosaccharides, Disaccharides, Monosaccharides, Polyols, Gastrointestinal Disorders, Irritable Bowel Syndrome, Gut Microbiota, Diet Intervention
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.